An analysis of findings regarding the prevalence and time course of symptoms and the results of neurobehavioral testing among Michigan and Wisconsin dairy farnmrs, is reported. Reviewed are: (1) differences in the prevalence of neurological symptoms at the time of examination; (2) differences in the incidence and time course of symptoms for the period 1972-1976; (3) differences among populations and subgroups (sex and age) regarding performance test scores; (4) correlations between performance test scores and neurological symptoms; and (5) correlations between serum PBB levels as indicators of exposure and performance tests and neurological symptoms. This is a report of findings regarding performance test scores and neurological symptoms in individuals suspected of being exposed to polybrominated biphenyls (PBB) in Michigan (primarily dairy farm residents) and within a control population of dairy farm residents in Wisconsin. Reviews of PBB toxicity and of the Michigan PBB incident have been published elsewhere (1-5). The present study was part of comprehensive medical field survey conducted by our Laboratory between November 1976 and March 1977 in Michigan and Wisconsin.
This is a report of findings regarding performance test scores and neurological symptoms in individuals suspected of being exposed to polybrominated biphenyls (PBB) in Michigan (primarily dairy farm residents) and within a control population of dairy farm residents in Wisconsin. Reviews of PBB toxicity and of the Michigan PBB incident have been published elsewhere (1) (2) (3) (4) (5) . The present study was part of comprehensive medical field survey conducted by our Laboratory between November 1976 and March 1977 in Michigan and Wisconsin.
The major questions addressed in this report include: (1) the prevalence of neurological symptoms in the Michigan population exposed to PBB and its difference from that in the Wisconsin, non-PBB exposed group; (2) differences in the incidence and time course of symptoms in the Michigan and Wisconsin populations for the period 1972-1976; (3) differences in standard performance test scores; (4) correlation between prevalence of symptoms (if found) with the results of objective performance test aimed at assessing neuropsychological dysfunction; (5) tion to the prevalence of neurological symptoms and/or the performance test scores; (6) correlations of performance test results with serum PBB levels; and (7) correlations between specific neurological symptoms and serum PBB levels.
Materials and Methods

Subjects
The symptoms of 644 adults from Michigan and 153 from Wisconsin were analyzed for prevalence and incidence of neuropsychological symptomatology. The characteristics of these two populations and patterns of symptoms other than neurological are discussed elsewhere in this issue (6) .
The subsample examined by means of performance tests were 102 males and 68 females from Michigan and 50 males and 43 females from Wisconsin. The subsample was chosen at random during comprehensive crosssectional clinical surveys in these two states. All examinees were whites. The educational level ranged from a few years of schooling to individuals with college degrees. The distribution of educational levels in the two populations is almost identical with a peak at a unit beApril 1978 tween 3-3.9, a rating corresponding to a high school degree or a little higher. The peaks of the age distribution for Michigan and Wisconsin were located at 35-44 and 45-54 years of age. The weight attributed to educational level and age in these tests has been discussed elsewhere (7) . Other factors being equal, the average scores of the Wisconsin sample are expected to be lower than the Michigan sample because of these differences (not statistically significant) in age. In a few cases and for a variety of reasons (such an interruption of the testing for compelling reasons or physical handicap) data for individual tests in some are missing.
Neurobehavioral Tests
Block Design (BD), Digit Symbol (DS), and Embedded Figures (EF) tests were used in the assessment of performance of the populations studied. The Block Design test is widely used in the evaluation of the effects of neurotoxic substances. The test provides a quick and objective measure of the subject's ability to visualize spatial relations. The examinee is presented with a set of colored cubes. Each cube has sides which are red, white, and half red and half white. The task requires arranging the cubes so that the top surface reproduces a displayed design. In the first six trials, only four of the cubes are used and the designs to be reproduced are relatively simple. In the last four trials, nine cubes are used and the designs are more complex. The score is based on the number of correctly completed trials as well as the speed with which the test is accomplished.
The Digit Symbol test assesses the subject's ability to associate symbols according to a code. The subject is given a list in which symbols are associated with digits from 1 to 9 and is asked to enter the symbols into the blank spaces next to a list of random digits on a form. The score is the number of symbols correctly entered in 90 sec.
The Embedded Figures test has been extensively used in neurological research, particularly during World War II. The test, consisting of four sets of superimposed outlines of common objects, assesses visual perception in masked conditions. The score is the total number of objects successfully identified in the four sets.
Reliability and Validity of Tests
Test-retest reliability data for the Block Design test and for the Digit Symbol test have been provided by Wechsler (8) . The test-retest correlation coefficient is between 0.82 and 0.85 for ages 18-54 and 0.80 for ages 16-24 respectively. The Embedded Figures test has been developed in our laboratory in studies of over 600 subjects classified by age, sex, race, education, occupation, geographic area, rural or urban living and native language (English and Spanish). This battery of tests has been shown to be sensitive in detecting subclinical central nervous system dysfunction as a result of excessive exposure to lead (7) .
All test scores correlated positively and significantly among themselves within the control and test population. Age correlated significantly and negatively with all behavioral test scores in both groups. Matrices of test intercorrelations are given in Tables 1 and 2 . Biological Indicators of Exposure PBB in blood serum was analyzed according to the procedure of Liddle, Price, and Bayse (9) . Since serum 1,1-dichloro-2,2-bis (p-chlorophenyl)-ethylene (DDE) was readily obtained in these analyses, it has been reported, in addition to PBB. DDE residues in humans are derived from accumulated environmental exposures to DDT and DDE, the latter occurring as a biological dehydrochlori- Briefly, a hexane-ether extract (3 x 5 ml) of methanol (2 ml)-treated serum (4 ml) was eluted through a Florisil (1.6 g) column topped with sodium sulfate. The first 13 ml hexane eluate was analyzed by electron-capture gas chromatography (63Ni detector) on a 3 ft x 1/4 in. 1% OV101 on 80/100 Supercoport glass column at 240TC. Retention times were approximately 8 min for hexabromobiphenyl, 20 min for heptabromobiphenyl, and 1.5 min for DDE. Recoveries of PBB from serum and standard solutions (hexane) and from serum (spiked with PBB in DMSO) of PBB were 97 + 12% and 94 + 11% (mean + standard deviation) respectively. Analysis for PBB was based on the major peak, 2,4,5-2' ,4' ,5'-hexabromobiphenyl.
Serum extracts were diluted to less than 500 ng/ml, which was well within the range of linearity of the detector for PBB. The limit of detectability (less than 1000 integrator area units) was ca. 5 pg total injection, and quantitative recovery of PBB from spiked serum samples was successful at 0.2 ppb.
Additional information on the results of PBB determinations in serum for these populations are reported herein (10, 11) .
Variables Considered in the Analysis of Data
The population examined (Michigan) was grouped according to whether the individuals resided on quarantined or nonquarantined farms or were consumers of products purchased from such farms or workers employed by Michigan Chemical Corporation, manufacturers of the PBB. The description of these groups has been reported (6) and a description of behavioral differences in these groups has been discussed (12) .
Other variables considered in the analysis of neurobehavioral data were: sex, race, age, education, results of behavioral test described above, PBB and DDE in serum, and symptoms before 1973 and in the period 1973-1976 as described above.
Statistical Analysis of Data
Correlation coefficients, computed among all variables, are presented as intercorrelation matrices for both Michigan and Wisconsin residents (Tables  1 and 2 ). Correlation coefficients were obtained for an equal number of cases within the Michigan group (173) and the Wisconsin group (93). t-tests for independent samples were computed to assess male vs. female and male vs. male and female vs. female differences (Tables 4 and 5) .
Results
Performance Tests Figure 1 depicts the mean of scores for three performance tests (BD, DS, and EF) in males (black bars) and females (white bars) in Michigan and Wisconsin for three age groups (0-29, 30-49, and > 50). Serum PBB and DDE levels mean values are also indicated. Statistical differences between males and females at the five and one percent level of significance are indicated by one and two asterisks, respectively. Table 4 contains numerical data corresponding to this illustration.
It was found that females scored better than males in the DS test both in Michigan and Wisconsin in the three age groups. However, for the Michigan subgroup of age 50 and over, males scored worse than females in two additional tests (BD and EF). Serum PBB level differences between males and females are highly significant in all three age groups in Michigan (Table 5) . Table 6 shows the correlation between age, serum PBB, DDE levels, and performance test scores for males and females from Michigan. Analysis of Environmental Health Perspectives similar data for the Wisconsin population is in progress. Group size and critical values for the evaluation of the significance of the correlation coefficients are shown at the bottom of each column. With one exception (the correlation coefficient of the BD test with serum PBB in females), correlation coefficients between performance test scores and serum PBB levels were negative, suggesting that a higher serum PBB level was associated with a lower performance test score. The only statistically significant correlation was that for EF test scores among males. Two test scores (DS and EF) were significantly and negatively correlated with serum DDE levels. Tables 1 and 2 contain the complete correlation matrices from which these data were derived. Table 7 shows the correlation coefficients between serum PBB and DDE levels and performance test scores for Michigan males in three age groups. Group size and critical values for the evaluation of the significance of the correlation coefficients are shown at the bottom of each column.
In males, the correlation coefficient between serum PBB levels and age showed a negative trend in the three age groups (+ 0.27, -0.20, and -0.69); no similar trend was observed in females (+ 0.19, + 0.37, and -0.36). As previously shown, the mean serum PBB levels for males were significantly higher than for females. In males, the correlation coefficient between serum DDE levels and age was increasingly positive (+ 0.08, + 0.21, and + 0.57) in the three consecutive age groups (statistically significant for the older group). In females, serum DDE level was significantly correlated with age in the two younger groups.
The correlation coefficients between BD, DS and EF test and serum PBB levels in males were progressively more negative as a function of age group but were not statistically significant. For the BD test, the values were + 0.18, -0.16, and -0.32; for the DS test, + 0.23, -0.007, and -0.41; and for the EF test, + 0.13, -0.16, and -0.57, respectively. No similar trend was observed in the magnitude of the correlation coefficients between test scores and serum PBB levels in females as a function of age group. A similar analysis for trends in the correlation coefficients between serum DDE levels and test scores revealed that these coefficients were negative and in one case (EF) significant in males of the oldest age group. No similar pattern was detected in females.
The behavioral findings analyzed by means of correlational techniques were convergent with those obtained from assessment of population differences ( Fig. 1 population. By this method it was possible to determine the approximate time of onset of the various symptoms reported by the examined persons at the five and one percent level of significance. The curves shown in Figure 4 represent the growth of the magnitude of the chi-square for individual symptoms as explained above. All symptoms for which a significant difference between the Michigan and Wisconsin examined population was found in 1976 are represented in decreasing order of magnitude of the chi-square value. It was found that neurological complaints represented the leading symptoms. All seemed to be reaching a plateau in 1976 but none decreased significantly over the years. Figure 5 illustrates the time course of each symptom as determined by the method described above. A temporal sequence was reconstructed according to their relative time of onset (the number in the scale indicates months as relative units). No attempt was made to determine the precise time of onset of the symptom although the relative time of onset could be ascertained. The dashed and solid lines indicate areas where the criterion for significance of 5 and 1%, respectively, was met. All the symptoms without exception listed in Table 3 were considered for this analysis, and only those showing significant differences when compared to the Wisconsin population are shown.
In the Michigan population, the onset of neurological symptoms preceded all others. The frequency of some of the symptoms, such as nausea and dizziness, increased slowly over the months whereas others, such as depression, nervousness, paresthesia, tiredness, sleepiness and headaches showed a more rapid increase in prevalence. Interestingly, "'motor involvement" such as loss of balance, muscle weakness, difficulty in walking, and blurred vision occurred relatively later in time or showed a slower rate of increase. Finally, the prevalence of symptoms such as increased perspiration, slower healing of cuts, and nail discoloration progressed slowly during 3-7 months. Some of these symptoms, such as increased perspiration, swelling of joints, and difficulty in walking were never reported significantly higher than at the 5% level, compared to the Wisconsin population. Tables 11 and 12 are summaries of data. Table 12 contains the evolution of symptoms as reconstructed from the special questionnaire and the method described above: the higher the position in the list, the earlier its occurrence. It is shown that the order in which symptoms have established themselves varies according to whether a less conservative criterion (5%) or a more conservative criterion (1%) was taken. However, in both cases neurological symptoms were the earliest manifestation of abnormalities in the Michigan population.
Discussion
Preliminary analysis of data reported here indicates that a significant constellation of neurological symptoms occurred among dairy farmers during the period 1972-1976, when patterns for a non-PBBexposed dairy farm population are taken as a reference. Simple statistical procedures demonstrate that neurological symptoms were also likely to be the earliest manifestations of abnormalities among the Michigan dairy farmers. Performance test results suggest that in older males, higher serum PBB levels were more likely to be associated with dysfunction.
Serum PBB levels are significantly higher in males than in females in all age groups and, in general, performance test scores are lower in males than in females. However, since in some tests, such as the DS test, women scored better than males in the reference population also, interpretation of these results should be made with caution. However, after considering these factors, there is a distinctive group of males (50 and over) which performed significantly less well than the control population.
Analysis of correlations between symptoms and serum PBB levels in males and females of various age groups and between performance tests and neurological symptoms is still in progress. PBB levels in depot fat biopsies are expected to be available and will add another dimension to this analysis. It is possible that fat PBB levels may be even more closely related to neurobehavioral symptoms and behavioral test scores.
As determined at one specific point in time (November 1976), neurological symptoms that are significantly more prevalent in Michigan seemed to have reached a plateau.
We attempted to eliminate descriptions of anecdotal type, although the descriptions-such as numerous reports of marked memory difficultiesilluminate the symptomatology that we describe here only briefly. In this report, our analysis was restricted to those data which could be documented as objectively as possible. Fig. 3 
